Skip to main content

Another important step for Orthocell

02/12/2024 - 15:00

Bookmark

Save articles for future reference.

Biotech firm Orthocell is a step closer to its nerve repair device Remplir being approved in the US, following the completion of its US regulatory study.

To read our articles you will need to either login or subscribe.